TherVacB Project Follow 123 305
#TherVacB is a #H2020 research project developing a #therapeutic #vaccine to #cure #hepatitisB patients.
It's #InternationalClinicalTrialsDay! 🎉Join the ongoing event by #ICTD2021 to discuss Platform #Clinicaltrial: Shift in treatment, #testing and collaboration 👉https://ecrin.org/events/ictd2021 🥼🔬💉👨🔬👩🔬
#SpringTestingWeek #EuroTestWeek #EndHep #Europe #LiverCancer #EUCancerPlan
#ILC2021 #NASHday @EU_Health @ECDC_HIVAIDS @EASLnews @rixwolff @JVLazarus @ECDC_EU @Hep_Alliance #NOhep @SKyriakidesEU @hans_kluge @Marko_Korenjak #NOhep
@GLOBOCAN_GCO @HepCPartnership @LiverTrust
It is recommended all babies and adolescents be vaccinated against Hep B. Some adults may also be at greater risk of contracting Hep B. Check our guide to see if you fall in the recommended category for a Hep B vaccination.
Hepatitis B Guide
Testing, treatment and staying healthy. This guide is to help you understand the process from being tested for hep...
#NOhep Medical Visionary Manal El-Sayed has been a strong advocate for change both in her country and internationally, and has used her voice to fight for viral #hepatitis to be recognised as a public health threat.
Find out more about her amazing work:
NOhep Medical Visionary: Dr Manal El-Sayed
Dr Manal El-Sayed is an exemplar of what can be achieved through raising awareness and education for viral hepatitis.
May 13, 2021
Translations of the revised TherVacB website are now available in four languages! To make info about the TherVacB vaccination study and the European HBV Registry more accessible to a Europen audience, we have partnered with researchers at study centres to produce this...
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 848223.